Search

Your search keyword '"Sadzot-Delvaux C"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Sadzot-Delvaux C" Remove constraint Author: "Sadzot-Delvaux C"
111 results on '"Sadzot-Delvaux C"'

Search Results

18. Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)

22. In vitro and in vivo modulation of 5-hydroxytryptamine-, thyrotropin-releasing hormone- and calcitonin-gene related peptide-like immunoreactivities in adult rat sensory neurons

27. Varicella-zoster virus infection of adult rat sensory neurons in vitro

28. [Lethal varicella. Immunohistochemistry and in situ hybridization]

29. Varicella vaccination in Europe – taking the practical approach

30. Varicella vaccination in Europe - taking the practical approach.

31. Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids.

32. Lack of strong innate immune reactivity renders macrophages alone unable to control productive Varicella-Zoster Virus infection in an isogenic human iPSC-derived neuronal co-culture model.

33. Activation of Interferon-Stimulated Genes following Varicella-Zoster Virus Infection in a Human iPSC-Derived Neuronal In Vitro Model Depends on Exogenous Interferon-α.

34. Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4 + GBM cells: A proof of principle.

35. [Contribution of GIGA I3 (GIGA-Infection, Immunity and Inflammation) to the understanding of the complex pathogen-host-environment interplay].

36. Varicella-Zoster Virus ORF9p Binding to Cellular Adaptor Protein Complex 1 Is Important for Viral Infectivity.

37. Deletion of the ORF9p acidic cluster impairs the nuclear egress of varicella-zoster virus capsids.

38. Varicella-zoster virus induces the formation of dynamic nuclear capsid aggregates.

39. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

40. ORF9p phosphorylation by ORF47p is crucial for the formation and egress of varicella-zoster virus viral particles.

41. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3.

42. Innate immune response and viral interference strategies developed by human herpesviruses.

43. The Varicella-Zoster virus IE4 protein: a conserved member of the herpesviral mRNA export factors family and a potential alternative target in antiherpetic therapies.

44. Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway.

45. Varicella vaccination in Japan, South Korea, and Europe.

46. Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

47. The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner.

48. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine.

49. [Varicelle zoster virus, an alphaherpesvirus different from others].

50. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.

Catalog

Books, media, physical & digital resources